Skip to content

Non invasive investigation of the metabolic capacity of the tibialis anterior muscle using 31P magnetic resonance spectroscopy

Non invasive investigation of the metabolic capacity of the tibialis anterior muscle using 31P magnetic resonance spectroscopy - 31P-MRS of tibialis anterior muscle

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON40317
Enrollment
15
Registered
2014-07-23
Start date
2015-02-05
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

N/A

Interventions

Muscle contractions inside the MR scanner will be used to disturb the metabolic steady state of the tibialis anterior. Non-invasive 31P-MRs will be performed before, during, and after these muscle c

Sponsors

Universitair Medisch Centrum Sint Radboud
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Potential volunteers must meet all of the following inclusion criteria: -healthy -male -young: between 18 to 35 years -BMI between 19 and 25 kg/m2 -MR compatibility is verified using a questionnnaire

Exclusion criteria

Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: -Epilepsy or medication against epilepsy -Subject is not MR compatible (e.g. because of pacemaker, claustrophobia, metal implants in the lower leg that may interfere with MRS, metal splinters in the eye)

Design outcomes

Primary

MeasureTime frame
Main endpoint is the rate of PCr recovery after exercise for the different regions of the TA muscle.

Secondary

MeasureTime frame
The utilization of PCr, the buildup of inorganic phosphate, and the effect of exercise on pH during the muscle contractions are secondary endpoints. All these parameters can be obtained from the same MR spectrum can therefore be measured simultaneously.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)